AEHR EVP of R&D receives 2,369-share stock award
WIMMERS DIDIER reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
WIMMERS DIDIER reported acquisition or exercise transactions in this Form 4 filing.
AEHR TEST SYSTEMS Executive VP of R&D Didier Wimmers received an equity award of 2,369 shares of common stock in the form of restricted stock units at no cash cost. Following this grant, he directly holds 12,696 shares, including unvested restricted stock units. One-sixteenth of the total restricted stock units will vest at the end of each three full calendar months after the grant date, as long as he remains employed by the company on those dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,369 | $0.00 | $0.00 |
Footnotes (2)
- F1. One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates.
- F2. The amount reported includes shares subject to unvested restricted stock units.
Key Figures
Key Terms
restricted stock unit financial
vest financial
unvested restricted stock units financial
Executive VP of R&D financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AEHR Executive VP of R&D Didier Wimmers report?
What is the vesting schedule for Didier Wimmers’ AEHR restricted stock units?
AI-generated analysis. How Rhea-AI works. Not financial advice.